Antisera induced by infusions of autologous Ad-CD154-leukemia B cells identify ROR1 as an oncofetal antigen and receptor for Wnt5a
Fukuda, Tetsuya, Chen, Liguang, Endo, Tomoyuki, Tang, Li, Lu, Desheng, Castro, Januario E, Widhopf, George F. II, Rassenti, Laura Z, Cantwell, Mark J, Prussak, Charles E, Carson, Dennis A, Kipps, Thomas J
Published in Proceedings of the National Academy of Sciences - PNAS (26.02.2008)
Published in Proceedings of the National Academy of Sciences - PNAS (26.02.2008)
Get full text
Journal Article
Phase I Trial: Cirmtuzumab Inhibits ROR1 Signaling and Stemness Signatures in Patients with Chronic Lymphocytic Leukemia
Choi, Michael Y., Widhopf, George F., Ghia, Emanuela M., Kidwell, Reilly L., Hasan, Md Kamrul, Yu, Jian, Rassenti, Laura Z., Chen, Liguang, Chen, Yun, Pittman, Emily, Pu, Minya, Messer, Karen, Prussak, Charles E., Castro, Januario E., Jamieson, Catriona, Kipps, Thomas J.
Published in Cell stem cell (01.06.2018)
Published in Cell stem cell (01.06.2018)
Get full text
Journal Article
CD40-ligand (CD154) gene therapy for chronic lymphocytic leukemia
Wierda, William G., Cantwell, Mark J., Woods, Sandra J., Rassenti, Laura Z., Prussak, Charles E., Kipps, Thomas J.
Published in Blood (01.11.2000)
Published in Blood (01.11.2000)
Get full text
Journal Article
Development and Testing of a Glycoengineered Anti-ROR1 Antibody with Enhanced Capacity for Directing Antibody-Dependent Cellular Cytotoxicity (ADCC) of Chronic Lymphocytic Leukemia Cells
Hasan, Md Kamrul, Widhopf II, George, Oh, Christopher, Girgis, Christina, Prussak, Charles E., Breitmeyer, James B., Kipps, Thomas J.
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Preclinical evaluation of anti-ROR1 CAR T cells employing a ROR1 binding SCFV derived from the clinical stage mab cirmtuzumab
Prussak, Charles E., Oh, Christopher, Velez Lujan, Juliana, Lam, Sharon, Zhang, Jieyu, Fernandez, Jayde, Sinha, Navyaa, Pham, Jessica, Shi, Haoming, Shin, Caitlin, Kaufman, Gunnar F., Widhopf II, George F., Cohen, Ezra E.W., Kipps, Thomas J.
Published in Journal of clinical oncology (10.02.2020)
Published in Journal of clinical oncology (10.02.2020)
Get full text
Journal Article
Durable and Specific Inhibition of ROR1 Signaling Associates with Prolonged Progression Free Survival in Patients with Chronic Lymphocytic Leukemia Treated with Cirmtuzumab
Choi, Michael, Widhopf II, George F., Yu, Jian, Chen, Liguang, Hasan, Md. Kamrul, Rassenti, Laura Z., Pittman, Emily, Messer, Karen, Gutierrez, Charlene, Kidwell, Reilly Lilianna, Prussak, Charles E., Castro, Januario E, Jamieson, Catriona, Kipps, Thomas J.
Published in Blood (08.12.2017)
Published in Blood (08.12.2017)
Get full text
Journal Article
Abstract 5967: Blockade of Wnt5A/ROR1 signaling as cancer stem cell targeting therapy for metastatic prostate cancer
Jamieson, Christina A.M., Murtadha, Jamillah, Oh, Christopher S., Muldong, Michelle T., Etemadfard, Niloofar, Koutouan, Evodie, Yoon, Young E., Lee, Sanghee, Kwon, Oh, Oh, Jong J., Kim, Min S., Willert, Karl, Cacalano, Nicholas A., Jamieson, Catriona H.M., Gaasterland, Terry, Mckay, Rana R., Kane, Christopher J., Kulidjian, Anna A., Prussak, Charles E.
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Get full text
Journal Article
CD40-ligand (CD154) gene therapy for chronic lymphocytic leukemia
Wierda, William G., Cantwell, Mark J., Woods, Sandra J., Rassenti, Laura Z., Prussak, Charles E., Kipps, Thomas J.
Published in Blood (01.11.2000)
Published in Blood (01.11.2000)
Get full text
Journal Article
Cirmtuzumab Vedotin (UC-961ADC3), An Anti-ROR1-Monomethyl Auristatin E Antibody-Drug Conjugate, Is a Potential Treatment For ROR1-Positive Leukemia and Solid Tumors
Cui, Bing, Widhopf, George F., Prussak, Charles E., Wu, Christina C.N., Sadarangani, Anil, Zhang, Suping, Lao, Fitzgerald, Jamieson, Catriona HM, Carson, Dennis A., Kipps, Thomas J.
Published in Blood (15.11.2013)
Published in Blood (15.11.2013)
Get full text
Journal Article